Furthermore, comparative studies focusing on potential differences in ieMMC and stromal MC occurrence between human samples and genetically similar specimens derived from murine models (e.g., BRAF-, KRAS-mutated tumors) combined with the prognostic assessment of MCs in human CRC should be conducted in the future. Here, KRAS is linked to colorectal carcinoma.